Status:
UNKNOWN
Study on the Myocardial Protective Effect of Upper Limb Ischemic Preconditioning in Patients Undergoing Off-pump Coronary Artery Bypass Grafting
Lead Sponsor:
Shanghai Zhongshan Hospital
Conditions:
OPCABG
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The purpose of the study was to verify the myocardial protective effect of RIPC in patients undergoing OPCABG.
Detailed Description
66 patients scheduled for OPCABG are randomly assigned to a RIPC group(n=33) or a control group(n=33). In the RIPC group, 4 cycles of 5-min ischemia(using a blood pressure cuff inflated to 40mmHg over...
Eligibility Criteria
Inclusion
- serious changes in several coronary arteries that need to receive OPCABG
- NHYA II-III
- ASA II-III
Exclusion
- LVEF\< 35%
- acute myocardial infarction
- multiple organ dysfunction
Key Trial Info
Start Date :
November 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2019
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT03340181
Start Date
November 1 2017
End Date
June 30 2019
Last Update
November 13 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Huilin Wang
Shanghai, Shanghai Municipality, China, 200233